157 related articles for article (PubMed ID: 22304408)
1. Leukemia inhibitory factor: a paracrine mediator of bone metabolism.
Sims NA; Johnson RW
Growth Factors; 2012 Apr; 30(2):76-87. PubMed ID: 22304408
[TBL] [Abstract][Full Text] [Related]
2. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
3. LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.
Sasaki N; Shinomi M; Hirano K; Ui-Tei K; Nishihara S
Stem Cells; 2011 Apr; 29(4):641-50. PubMed ID: 21305673
[TBL] [Abstract][Full Text] [Related]
4. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
[TBL] [Abstract][Full Text] [Related]
6. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
7. Free LIF receptor α-chain distal cytoplasmic motifs enhance Jak2-independent STAT3 phosphorylation and induce differentiation in HL-60 cells.
Sun Q; Wang J; Xiong J; Yang L; Liu H
Oncol Rep; 2011 Aug; 26(2):399-404. PubMed ID: 21567092
[TBL] [Abstract][Full Text] [Related]
8. Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization.
Poulton IJ; McGregor NE; Pompolo S; Walker EC; Sims NA
J Bone Miner Res; 2012 Mar; 27(3):586-95. PubMed ID: 22143976
[TBL] [Abstract][Full Text] [Related]
9. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
10. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone.
Malaval L; Gupta AK; Liu F; Delmas PD; Aubin JE
J Bone Miner Res; 1998 Feb; 13(2):175-84. PubMed ID: 9495510
[TBL] [Abstract][Full Text] [Related]
11. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.
Gregg C; Weiss S
Development; 2005 Feb; 132(3):565-78. PubMed ID: 15634701
[TBL] [Abstract][Full Text] [Related]
12. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
13. Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion.
Kirsch M; Trautmann N; Ernst M; Hofmann HD
Glia; 2010 May; 58(7):768-79. PubMed ID: 20091786
[TBL] [Abstract][Full Text] [Related]
14. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
15. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
[TBL] [Abstract][Full Text] [Related]
16. Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells.
Wang T; Yan R; Xu X; Yu H; Wu J; Yang Y; Li W
Mol Med Rep; 2019 Jun; 19(6):4719-4726. PubMed ID: 31059010
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor influences the fate choice of mesenchymal progenitor cells.
Falconi D; Oizumi K; Aubin JE
Stem Cells; 2007 Feb; 25(2):305-12. PubMed ID: 17284649
[TBL] [Abstract][Full Text] [Related]
18. LIF inhibits osteoblast differentiation at least in part by regulation of HAS2 and its product hyaluronan.
Falconi D; Aubin JE
J Bone Miner Res; 2007 Aug; 22(8):1289-300. PubMed ID: 17451373
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
